Human parathyroid peptide treatment of vertebral osteoporosis.

Human parathyroid peptide treatment of vertebral osteoporosis.

Previous studies have shown that treatment with daily injections of human parathyroid peptide (hPTH) 1-34 increase axial cancellous bone mass partially at the expense of peripheral cortical bone. In the present work the same hPTH 1-34 regime given for 12 months has been combined with oestrogen or na...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Reeve, J, Arlot, M, Bradbeer, J, Hesp, R, Mcally, E, Meunier, P, Zanelli, J
Format:	Journal article
Sprog:	English
Udgivet:	Springer-Verlag 1993

Lignende værker

Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
af: Bradbeer, J, et al.
Udgivet: (1992)

Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.
af: Arlot, M, et al.
Udgivet: (1993)

Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
af: Reeve, J, et al.
Udgivet: (1987)

A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
af: Reeve, J, et al.
Udgivet: (1986)

Iliac trabecular bone formation predicts radial trabecular bone density changes in type 1 osteoporosis.
af: Hesp, R, et al.
Udgivet: (1991)

Bone remodelling does not decline after menopause in vertebral fracture osteoporosis.
af: Wand, J, et al.
Udgivet: (1992)

Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
af: Tellez, M, et al.
Udgivet: (1995)

Bone density trends in the distal radius correlate with an index of axial osteoblast depression in osteoporosis
af: Reeve, J, et al.
Udgivet: (1986)

Osteoblast density and the evolution of BMUs in vertebral osteoporosis
af: Brown, M, et al.
Udgivet: (1993)

Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.
af: Reeve, J, et al.
Udgivet: (2001)

Bone formation and osteoid mineralization in osteoporosis
af: Reeve, J, et al.
Udgivet: (1984)

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
af: Reeve, J, et al.
Udgivet: (1991)

Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
af: Reeve, J, et al.
Udgivet: (1981)

Peripheral and axial measurements of trabecular bone density in patients suspected of idiopathic vertebral osteoporosis.
af: Bydder, G, et al.
Udgivet: (1983)

The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
af: Hesp, R, et al.
Udgivet: (1981)

Effects of Two Treatment Regimes with Synthetic Human Parathyroid Hormone Fragment on Bone Formation and the Tissue Balance of Trabecular Bone in Greyhounds
af: Podbesek, R, et al.
Udgivet: (1983)

The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics.
af: Reeve, J, et al.
Udgivet: (1987)

Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
af: Arlot, M, et al.
Udgivet: (1984)

Reduced calcification activity in normal-thickness osteoid in crush fracture osteoporosis: Association with vitamin D status
af: Reeve, J, et al.
Udgivet: (1987)

Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens
af: Reeve, J, et al.
Udgivet: (1986)

Parathyroid Hormone in Osteoporosis Treatment
af: İ. Özkul
Udgivet: (2002-03-01)

The relationship between serum vitamin D concentrations and in vivo tetracycline labeling of osteoid in crush fracture osteoporosis.
af: Mawer, E, et al.
Udgivet: (1991)

Relationship between the location of osteoblastic alkaline phosphatase activity and bone formation in human iliac crest bone.
af: Bradbeer, J, et al.
Udgivet: (1992)

Recombinant human parathyroid hormone.
af: Reeve, J
Udgivet: (2002)

Osteoporosis: cause and management
af: Reeve, J, et al.
Udgivet: (1987)

Recombinant human parathyroid hormone - Reply
af: Reeve, J
Udgivet: (2002)

Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
af: Podbesek, R, et al.
Udgivet: (1984)

A new tracer method for the calculation of rates of bone formation and breakdown in osteoporosis and other generalised skeletal disorders
af: Reeve, J, et al.
Udgivet: (1977)

Whole-body and site-specific bone remodelling in patients with previous femoral fractures: relationships between reduced physical activity, reduced bone mass and increased bone resorption.
af: Wand, J, et al.
Udgivet: (1992)

Trends in trabecular and cortical bone in the radius compared with whole body calcium balance in osteoporosis.
af: Hesp, R, et al.
Udgivet: (1984)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
af: Richard G. Pearson, et al.
Udgivet: (2019-06-01)

Suggestive linkage of the parathyroid receptor type 1 to osteoporosis.
af: Duncan, E, et al.
Udgivet: (1999)

Suggestive linkage of the parathyroid receptor type 1 to osteoporosis
af: Duncan, E, et al.
Udgivet: (1999)

Trabecular and cortical bone in the radii of women with parathyroid adenomata: a greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy.
af: Hesp, R, et al.
Udgivet: (1987)

Regional bone density measurements compared to total body calcium in osteoporosis
af: Hesp, R, et al.
Udgivet: (1982)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
af: Lundkvist, J, et al.
Udgivet: (2006)

Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
af: Scoutellas, V, et al.
Udgivet: (1999)

Fluctuation of mineral apposition rate at individual bone-remodeling sites in human iliac cancellous bone: independent correlations with osteoid width and osteoblastic alkaline phosphatase activity.
af: Bradbeer, J, et al.
Udgivet: (1994)

Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS).
af: Lunt, M, et al.
Udgivet: (2003)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
af: Esteban Jódar-Gimeno
Udgivet: (2007-04-01)